Depression and Anxiety Trial, Recruiting (NCT07278466)

Depression and Anxiety Trial, Recruiting NCT07278466 Sponsor: University of Wisconsin, Madison Condition: Depression and Anxiety

Printed from Voxsanity (voxsanity.com.au) — NCT07278466 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Depression And Anxiety

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are experiencing significant symptoms of depression and/or anxiety, based on scores from standard questionnaires (a score of 10 or higher on the PHQ-9 depression scale and/or a score of 10 or higher on the GAD-7 anxiety scale)
People who can read and communicate in English
People who have access to a smartphone and the internet
People who are able to receive text messages on their phone

Who may not be able to join:

People who are not a US citizen or a legal permanent resident (green card holder)
People who have a history of psychosis or mania
People who are currently experiencing thoughts of suicide or self-harm, as identified by specific questions on the PHQ-9 and BDI questionnaires
People who do not provide the personal information needed to generate a required identification code for the study (confirm with trial site)
People who have previously taken part in this trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 12 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Simon Goldberg, PhD, UW Madison

Phone: 608-890-2747

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07278466

Sponsor: University of Wisconsin, Madison

Phase: Not Applicable

Status: Recruiting

Condition: Depression and Anxiety

Trial contact: 608-890-2747

More information: https://clinicaltrials.gov/study/NCT07278466

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are experiencing significant symptoms of depression and/or anxiety, based on scores from standard questionnaires (a score of 10 or higher on the PHQ-9 depression scale and/or a score of 10 or higher on the GAD-7 anxiety scale)
People who can read and communicate in English
People who have access to a smartphone and the internet
People who are able to receive text messages on their phone

Who may not be able to join:

People who are not a US citizen or a legal permanent resident (green card holder)
People who have a history of psychosis or mania
People who are currently experiencing thoughts of suicide or self-harm, as identified by specific questions on the PHQ-9 and BDI questionnaires
People who do not provide the personal information needed to generate a required identification code for the study (confirm with trial site)
People who have previously taken part in this trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 12 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Wisconsin, Madison

Registry

ClinicalTrials.gov

Start date

13 March 2026

Est. completion

31 January 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS) Score; Anxiety Measured from Evening Daily Diary Items; Depression Measured from Evening Daily Diary Items

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov